Trial Profile

Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 29 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs GSK 137173A (Primary) ; AS01B; AS01E
Indications Herpes zoster
Focus Pharmacodynamics
Sponsors GlaxoSmithKline; GSK

Most Recent Events

16 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
23 Feb 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
23 Feb 2010 Planned end date changed from 1 Nov 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com